Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bempedoic Acid Pregnancy Surveillance Program
Sponsor: Esperion Therapeutics, Inc.
Summary
Bempedoic acid pregnancy surveillance program
Official title: A Post-marketing, Long-term, Observational, Descriptive Study to Assess the Risk of Pregnancy and Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Women Exposed to Bempedoic Acid or Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) During Pregnancy
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2021-09-01
Completion Date
2032-05
Last Updated
2024-05-17
Healthy Volunteers
Not specified
Conditions
Interventions
Bempedoic Acid
Bempedoic Acid 180 MG
Bempedoic Acid / Ezetimibe
Bempedoic Acid 180 MG / Ezetimibe 10 MG
Locations (1)
Evidera, PPD business unit
Morrisville, North Carolina, United States